Michael Ferguson

Michael Ferguson has a diverse work experience spanning over several roles and industries. Michael is currently working as a Medical Sales Director at B-Secur starting from October 2021. Prior to this, from 2019 to 2021, they held the position of Regional Sales Director at BIOTRONIK, where they successfully managed the company's cardiac rhythm management portfolio in Northern UK and Ireland, leading to significant market share gains.

Before joining BIOTRONIK, from 2018 to 2019, Michael served as the Head of CRM Marketing & Education for Abbott. In this role, they led a large marketing and education team, equipping the UK sales and technical functions with the necessary materials and knowledge to capture market share.

Furthermore, Michael has extensive experience with Medtronic. From 2009 to 2017, they worked as a Senior UK District Business Manager, overseeing district sales operations. Prior to this, they held the positions of Scottish National District Manager and Market Development Manager at Medtronic from 2006 to 2009 and 2004 to 2006, respectively.

Earlier in their career, Michael worked as a Principal Analyst at Deutsche Bank from 1998 to 2004. Their responsibilities included managing a portfolio of analytical investment products focused on global Pharma, Biotech, and Healthcare companies. Michael extensively traveled to major markets like the USA, Europe, and Japan, collaborating with senior executives and investor relations.

Lastly, from 1995 to 1998, Michael worked as a Pharmacoeconomist at Glaxo Wellcome.

Overall, Michael Ferguson's work experience reflects their expertise in sales management, marketing, education, and investment analysis within the healthcare industry.

Michael Ferguson earned a Bachelor of Science (BSc) degree in Pharmacology and Physiology from the University of St Andrews. This was completed between the years 1989 and 1993. Subsequently, they pursued a Master of Science (MSc) degree in Pharmacoeconomics/Pharmaceutical Economics at the same university, graduating in 1995.